These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38872492)

  • 1. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
    Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential associations between selenoprotein P and distal sensorimotor polyneuropathy in people with and without diabetes: KORA F4/FF4 study.
    Herder C; Saito Y; Spagnuolo MC; Maalmi H; Shimizu M; Bönhof GJ; Suzuki K; Rathmann W; Peters A; Roden M; Ziegler D; Thorand B; Takamura T
    Free Radic Biol Med; 2024 Oct; 223():87-95. PubMed ID: 39059514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Schneider A; Zhang S; Wolf K; Maalmi H; Huth C; Pickford R; Laxy M; Bönhof GJ; Koenig W; Rathmann W; Roden M; Peters A; Thorand B; Ziegler D
    Environ Health Perspect; 2020 Dec; 128(12):127013. PubMed ID: 33356516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study.
    Maalmi H; Herder C; Huth C; Rathmann W; Bönhof GJ; Heier M; Koenig W; Roden M; Peters A; Ziegler D; Thorand B
    Int J Obes (Lond); 2022 Jul; 46(7):1366-1374. PubMed ID: 35474356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort.
    Schlesinger S; Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Bönhof GJ; Koenig W; Heier M; Peters A; Meisinger C; Roden M; Thorand B; Ziegler D
    Diabetes Care; 2019 Feb; 42(2):240-247. PubMed ID: 30523031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental risk factors of incident distal sensorimotor polyneuropathy: Results from the prospective population-based KORA F4/FF4 study.
    Herder C; Zhang S; Wolf K; Maalmi H; Bönhof GJ; Rathmann W; Schwettmann L; Thorand B; Roden M; Schneider A; Ziegler D; Peters A
    Sci Total Environ; 2023 Feb; 858(Pt 3):159878. PubMed ID: 36328258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study.
    Herder C; Kannenberg JM; Carstensen-Kirberg M; Strom A; Bönhof GJ; Rathmann W; Huth C; Koenig W; Heier M; Krumsiek J; Peters A; Meisinger C; Roden M; Thorand B; Ziegler D
    Diabetes; 2018 Nov; 67(11):2434-2442. PubMed ID: 30115651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
    Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
    BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study.
    Herder C; Bongaerts BW; Rathmann W; Heier M; Kowall B; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2015 Jan; 38(1):91-6. PubMed ID: 25325880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study.
    Bongaerts BW; Rathmann W; Heier M; Kowall B; Herder C; Stöckl D; Meisinger C; Ziegler D
    Diabetes Care; 2013 May; 36(5):1141-6. PubMed ID: 23275355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study.
    Herder C; Bongaerts BW; Rathmann W; Heier M; Kowall B; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D
    Diabetes Care; 2013 Nov; 36(11):3663-70. PubMed ID: 24009302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
    J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
    Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
    Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.
    Herder C; Kannenberg JM; Carstensen-Kirberg M; Huth C; Meisinger C; Koenig W; Peters A; Rathmann W; Roden M; Thorand B
    Cardiovasc Diabetol; 2017 Jan; 16(1):17. PubMed ID: 28143481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical screening score for diabetic polyneuropathy: KORA F4 and AusDiab studies.
    Bongaerts BW; Ziegler D; Shaw JE; Heier M; Kowall B; Herder C; Roden M; Peters A; Meisinger C; Rathmann W
    J Diabetes Complications; 2015; 29(1):44-9. PubMed ID: 25457462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
    Aso Y; Iijima T; Jojima T; Saito M; Tanuma D; Kase M; Sakurai S; Tomaru T; Usui I
    Postgrad Med; 2024 Apr; 136(3):318-324. PubMed ID: 38660919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.